Advises clients on telehealth, remote patient monitoring, AI-enabled tools, consumer wellness and other virtual care or digital health companies on product development, compliance, commercialization, and reimbursement strategies

Guides clients on structuring compliant care delivery models, navigating multi-state licensure, and advising on fraud and abuse, data privacy, cybersecurity, and other key areas

Advises mail order, retail and other types of pharmacies, suppliers and manufacturers on partnerships with healthcare companies and related compliance considerations

Develops compliance frameworks for consumer wellness programs and mobile health solutions

Leads retailers, tech companies and other non-healthcare companies through their development and launch of healthcare products or offerings

Structures provider networks and strategic collaborations among hospitals, health centers, and physicians

Counsels investors on healthcare trends, reimbursement opportunities and changes in laws to assist with designing their investment strategies

Patrick Zanayed represents private equity funds, digital health companies, strategic investors, ambulatory surgery centers, behavioral health facilities, senior care facilities, physician practices, and dental practices in a variety of transactional and regulatory matters. He also has deep experience advising on pharma services, clinical research, and health technology transactions.

Patrick has assisted clients in connection with numerous transactions, including mergers, acquisitions, dissolutions, and management and professional service arrangements, as well as the creation of multi-state physician practice management and telehealth structures. He also regularly advises clients with respect to corporate practice of medicine laws, state and federal telehealth laws, pharmacy laws, the fraud and abuse laws including the Anti-Kickback Statute, Beneficiary Inducements Civil Monetary Penalty Law, the Stark law and other federal and state legal, regulatory and business issues affecting healthcare providers and facilities.

Sam Siegfried is a trusted advisor on emerging healthcare technology matters, with a particular focus on data privacy and security, artificial intelligence (AI), clinical research, and complex technology transactions. He helps healthcare and life sciences companies navigate evolving regulations, maximize data-driven opportunities, and implement innovative technologies. He also conducts privacy and research diligence and negotiates transition services agreements for mergers and acquisitions, strategic investments, and joint ventures.

With extensive experience in key privacy frameworks, including the Health Insurance Portability and Accountability Act (HIPAA), the California Consumer Privacy Act (CCPA), Washington’s My Health My Data Act (MHMDA), the General Data Protection Regulation (GDPR), and other evolving US and global data protection frameworks, Sam provides critical data strategy guidance to digital health platforms, genomic sequencing providers, health systems, biotech firms, and other health and life sciences organizations.

As AI reshapes healthcare delivery and innovation, Sam works closely with AI developers and deployers on AI governance programs, generative AI use, and consumer protection risks. In the clinical research space, he advises on federal and state research regulations, research compliance program development, research informed consent, and Institutional Review Board (IRB) requirements.

Beyond his regulatory practice, Sam structures and negotiates complex commercial transactions, including data licensing agreements, software as a service (SaaS) and other technology platform agreements, AI development partnerships, research collaborations, and clinical trial agreements.

Before joining McDermott, Sam served as in-house counsel at an academic medical center and a precision medicine startup, handling complex privacy, research, and healthcare regulatory challenges. This frontline experience informs his pragmatic approach, allowing him to deliver solutions that seamlessly integrate compliance with business objectives.

Provides transactional and regulatory counseling to clients in the healthcare and life sciences industries 

Represents investors and their portfolio companies on M&A, joint ventures, and strategic affiliations  

Represents physician practices and other health organizations on corporate, regulatory compliance, and governance matters  

Advises digital health and health tech clients working at the intersection of healthcare, software, analytics, technology, AI, and electronic data